Table 1 Pattern of hRad17 staining by ovarian cancer subtype
From: Differential hRad17 expression by histologic subtype of ovarian cancer
Ovarian cancer subtype | Number of cases | hRad17 staining | Percent over-expressing hRad17 |
|---|---|---|---|
Benign | 9 | Nuclear | 13% |
Serous | 72 | Nuclear and cytoplasmic | 42% |
Endometrioid | 19 | Cytoplasmic | 47% |
Clear cell | 10 | Cytoplasmic | 80% |
Mucinous | 6 | Nuclear, cytoplasmic, and stromal | 100% |